retatrutide 2025 trial results 💉 may be redefining obesity treatment. New data from TRIUMPH-1 showed: 🔥 ~28% average weight loss over 80 weeks 🔥 >30% weight loss in nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic First Retatrutide phase 3 data,

Most reported issues are local and self-limiting

This review has also proposed a mechanism of LC- and ALC-induced enhancement of female fertility, (a) directly by increasing energy production in oocytes and effectively quenching free radicals to provide protection against oxidative damage to the reproductive cells, and also (b) indirectly, by imposing their beneficial effects through HPG axis to ameliorate serum levels of hormones

Patients with dark/brown urine and severe muscle pain should seek emergency care immediately

More recently, two fixed-ratio combinations of basal insulin and a GLP-1 RA that allow for once-daily dosing have been approved